Skip to content
Back to search
This tender has expired.

Hungary – Various medicinal products – Tételes immunglobulinok és egyéb hatóanyagok

Nemzeti Egészségbiztosítási AlapkezelőHungaryPublished on Jul 05, 2026
Deadline passed

Description

The procurement of immunoglobin and other active substances for the conclusion of a framework agreement, in the case of sections 1-9, according to the Kbt. 105. § (1) a) point, in the case of sections 10-11, according to the Kbt. 105. § (2) a) point, through an open procedure, with the possibility of extending the active period of the Framework Agreement. The subject of the current procurement procedure is as follows:

1. Part afatinib (OENO: 06022)

Base quantity: 611 520 mg

Optional quantity: 305 760 mg

Minimum mandatory product discount quantity for the base quantity: 2 240 mg

Minimum mandatory product discount quantity for the optional quantity: 1 120 mg

2. Part rizankizumab (OENO: 06083)

Base quantity: 858 300 mg

Optional quantity: 429 150 mg

Minimum mandatory product discount quantity for the base quantity: 300 mg

Minimum mandatory product discount quantity for the optional quantity: 150 mg

3. Part obinutuzumab (OENO: 06062)

Base quantity: 3 246 000 mg

Optional quantity: 1 623 000 mg

Minimum mandatory product discount quantity for the base quantity: 2000 mg

Minimum mandatory product discount quantity for the optional quantity: 1000 mg

4. Part tofacitinib (OENO: 06070)

Base quantity: 4 016 320mg

Optional quantity: 2 008 160 mg

Minimum mandatory product discount quantity for the base quantity: 560 mg

Minimum mandatory product discount quantity for the optional quantity: 280 mg

5. Part vedolizumab (OENO: 06005)

Base quantity: 3 203 400 mg

Optional quantity: 1 601 700 mg

Minimum mandatory product discount quantity for the base quantity: 600 mg

Minimum mandatory product discount quantity for the optional quantity: 300 mg

6. Part faricimab (OENO: 06099)

Base quantity: 164 793,6 mg

Optional quantity: 82 396,8 mg

Minimum mandatory product discount quantity for the base quantity: 57,6 mg

Minimum mandatory product discount quantity for the optional quantity: 28,8 mg

7. Part radium-223-dichloride (OENO: 06017)

Base quantity: 200 amp

Optional quantity: 100 amp

Minimum mandatory product discount quantity for the base quantity: 2 amp

Minimum mandatory product discount quantity for the optional quantity: 1 amp

8. Part Intravenous immunoglobulin, liquid, maltose stabilizer (OENO: 06044)

Base quantity: 26 000 000 mg

Optional quantity: 13 000 000 mg

AK does not prescribe a mandatory product discount, however, bidders have the possibility to offer a product discount.

9. Part Intravenous immunoglobulin, liquid, proline stabilizer (OENO: 06044)

Base quantity: 220 000 000 mg

Optional quantity: 110 000 000 mg

AK does not prescribe a mandatory product discount, however, bidders have the possibility to offer a product discount.

10. Part Intravenous immunoglobulin, liquid, sugar-free, glycine stabilizer (OENO: 06044)

Base quantity: 150 000 000 mg

Optional quantity: 75 000 000 mg

AK does not prescribe a mandatory product discount, however, bidders have the possibility to offer a product discount.

11. Part Subcutaneous immunoglobulin (OENO: 06044)

Base quantity: 200 000 000 mg

Optional quantity: 100 000 000 mg

AK does not prescribe a mandatory product discount, however, bidders have the possibility to offer a product discount.

The Inviting Entity draws the attention of the economic operators to the fact that, in accordance with the Kbt. 73. § (1) j) point:

- in the case of parts 1 and 3-11: the bid is invalid if it contains a higher bid price than the mg unit price calculated from the net wholesale price of the lowest-priced drug containing the relevant (parts-related) active substance defined in the PUPHA register on the date of the bid, and the total framework quantity multiplied by the total framework quantity.

- in the case of part 2: the bid is invalid if it contains a higher bid price than the net mg unit price calculated based on the last valid framework agreement and the total framework quantity multiplied by the total framework quantity, i.e. 7 579 218 150 Ft.

The BT-113 is to be completed due to technical reasons, AK does not wish to limit the maximum number of participants.

CPV codes

Various medicinal products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders